OTITOPIC
OtiTopic is a pharmaceutical company that engages in drug delivery and drug-device development services.
OTITOPIC
Social Links:
Industry:
Biotechnology Delivery Medical Device Pharmaceutical
Founded:
2012-01-01
Address:
Los Angeles, California, United States
Country:
United States
Website Url:
http://www.otitopic.com
Total Employee:
11+
Status:
Active
Contact:
877-443-8710
Email Addresses:
[email protected]
Technology used in webpage:
SPF Apache Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS CPanel SSL GoDaddy GoDaddy Email MarkMonitor DNS
Similar Organizations
Grace Therapeutics
Grace Therapeutics is a pharmaceutical company that focuses on drug delivery treatment for rare and orphan diseases.
Kalexsyn
Kalexsyn is a pharmaceutical company specializing in medicinal chemistry, custom synthesis, and process development services.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Current Employees Featured
Founder
More informations about "OtiTopic"
PMI progresses on acquisition of three pioneering …
Sep 20, 2021 Philip Morris International’s proposed acquisition of Vectura—and its completed acquisitions of Fertin Pharma and OtiTopic—will expand product pipeline development capabilities in inhaled and oral therapeutics, as well as …See details»
Philip Morris International Acquires Inhaled Drug Specialist …
Aug 9, 2021 OtiTopic was founded in 2012 as an innovative pharmaceutical start-up company and holds several key patents, differentiated intellectual property, and has confirmed a 505 …See details»
Media - Press Details | PMI - Philip Morris International
Aug 9, 2021 OtiTopic was founded in 2012 as an innovative pharmaceutical start-up company and holds several key patents, differentiated intellectual property, and has confirmed a 505 …See details»
Otitopic - ONdrugDelivery
Otitopic, acquired by tobacco company Philip Morris International in 2021, was a dry powder inhalation company with expertise in formulation and drug delivery …See details»
OtiTopic - Products, Competitors, Financials, Employees, …
Sep 20, 2023 OtiTopic is a late-stage pharmaceutical company, with a track record of success in product drug delivery and drug device development. On August 9th, 2021, OtiTopic was …See details»
OtiTopic 2025 Company Profile: Valuation, Investors ... - PitchBook
Information on acquisition, funding, investors, and executives for OtiTopic. Use the PitchBook Platform to explore the full profile.See details»
Otitopic, Inc. Company Profile | Westlake Village, CA | Competitors ...
Find company research, competitor information, contact details & financial data for Otitopic, Inc. of Westlake Village, CA. Get the latest business insights from Dun & Bradstreet.See details»
Philip Morris International Acquires Inhaled Drug …
Aug 9, 2021 LAUSANNE, Switzerland– Philip Morris International Inc. (PMI) (NYSE: PM) today announced its acquisition of OtiTopic, a U.S. respiratory drug development company with a late-stage inhalable acetylsalicylic acid (ASA) …See details»
Otitopic - Ownership and Business Overview | Mergr
OtiTopic is an innovative pharmaceutical start-up company that holds several key patents, differentiated intellectual property, and has confirmed a 505 (b)2 pathway through constructive …See details»
Philip Morris Bolsters 'Beyond Nicotine' Strategy with OtiTopic ...
Aug 9, 2021 For Philip Morris, the acquisition of OtiTopic builds on the company’s recent M&A activities to bolster its ‘Beyond Nicotine’ program. In July, PMI acquired Switzerland-based …See details»
Cigarette maker Philip Morris acquires another inhaled therapeutic ...
Aug 9, 2021 The company last month agreed to acquire inhaled drug delivery technology developer Vectura for $1.2 billion — a move that was met by resistance from the American …See details»
Philip Morris To Acquire OtiTopic - Quick Facts | Nasdaq
Aug 9, 2021 "The acquisition of OtiTopic is an exciting step in PMI's Beyond Nicotine ambitions," said Jacek Olczak, CEO, Philip Morris. Philip Morris expects the impact of the acquisition on …See details»
Philip Morris Bolsters 'Beyond Nicotine' Strategy with OtiTopic ...
Aug 9, 2021 Philip Morris continues to expand the tobacco giant's 'Beyond Nicotine' strategy by acquiring Michigan-based OtiTopic, a company developing inhalable acetylsalicylic acid (ASA) …See details»
Philip Morris Acquires Inhaled Respiratory Drug Company
Aug 10, 2021 Philip Morris International Inc. announced its acquisition of OtiTopic, a U.S. respiratory drug development company with a late-stage inhalable acetylsalicylic acid (ASA) …See details»
OtiTopic - Contacts, Employees, Board Members, Advisors & Alumni
OtiTopic is a pharmaceutical company that engages in drug delivery and drug-device development services.See details»
OtiTopic (USA) Funding - Medical Startups
Mar 11, 2025 OtiTopic's mission is to provide patients with a faster alternative for management of suspected myocardial infarction...See details»
Philip Morris International acquires inhaled drug specialist …
Aug 9, 2021 Philip Morris International Inc. (PMI) announced its acquisition of OtiTopic, a U.S. respiratory drug development company with a late-stage inhalable acetylsalicylic acid (ASA) …See details»
OTI Topic - Craft
See insights on OTI Topic including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Philip Morris International Acquires Inhaled Drug Specialist …
Aug 9, 2021 Philip Morris International Inc. today announced its acquisition of OtiTopic, a U.S. respiratory drug development company with a late-stage inhalable acetylsalicylic acid (ASA) …See details»
Hot topic detection and trend analysis in the field of maritime …
Feb 4, 2025 This paper employs the resolution documents of the Maritime Safety Committee (MSC) of the International Maritime Organization (IMO) in the field of maritime safety …See details»